{
  "scenario_id": "hg_screening_2025",
  "context": "Healthcare provider network, 100 hospitals, evaluating population genomics screening",
  "stakeholders": {
    "requester": "Chief Medical Officer",
    "approvers": [
      "CEO",
      "Chief Financial Officer",
      "Board Medical Committee"
    ],
    "influencers": [
      "VP Clinical Operations",
      "Genetics Experts",
      "Patient Advocacy Groups"
    ]
  },
  "request": {
    "amount": "$40,000,000",
    "purpose": "Population-scale genomics screening program implementation",
    "urgency": "high",
    "justification": "Preventive care improvement and personalized medicine advancement"
  },
  "decision_process": [
    {
      "stage": "clinical_evaluation",
      "duration": "12 weeks",
      "activities": [
        "Clinical evidence review",
        "Cost-effectiveness analysis",
        "Ethical considerations"
      ],
      "outcome": "Strong clinical evidence for preventive screening benefits"
    },
    {
      "stage": "operational_planning",
      "duration": "8 weeks",
      "activities": [
        "Program design",
        "Resource requirements",
        "Integration planning"
      ],
      "outcome": "Comprehensive implementation plan with phased rollout"
    },
    {
      "stage": "stakeholder_alignment",
      "duration": "6 weeks",
      "activities": [
        "Physician engagement",
        "Patient communication",
        "Regulatory approval"
      ],
      "outcome": "Approved with strong clinical and patient support"
    }
  ],
  "business_impact": {
    "expected_benefits": "Improved patient outcomes, reduced long-term costs, medical leadership position",
    "projected_revenue": "$150M in new preventive care services",
    "risk_factors": [
      "Data privacy concerns",
      "Clinical implementation complexity",
      "Reimbursement challenges"
    ]
  }
}
